Clinical trial
Methylphenidate and Response to Alcohol Cues (MARA) Pilot Study
NCT06063200 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Methylphenidate and Response to Alcohol Cues (MARA) Pilot Study
- Lead sponsor
- University of Florida
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 20, 2024
- Completion date
- July 1, 2025
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder, attention deficit hyperactivity disorder